Nantahala Capital Management »

Astria Therapeutics shares owned by Nantahala Capital Management

Quarter-by-quarter ownership of Astria Therapeutics (ATXS) shares owned by Nantahala Capital Management from 13F filings

Historical chart of Nantahala Capital Management investment in Astria Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Astria Therapeutics held by Nantahala Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Astria Therapeutics by Nantahala Capital Management

Quarter filed Position value Share count Share price at filing
2024-06-30 $6.1M 675k 9.10

More positions owned by Nantahala Capital Management

Ishares Tr Russell 2000 Etf (IWM)
Ishares Tr Russell 2000 Etf (IWM)
Eli Lilly & Co. Put Option (LLY)
Eli Lilly & Co. Put Option (LLY)
Soleno Therapeutics (SLNO)
Soleno Therapeutics (SLNO)
Establishment Labs Holdings Ord (ESTA)
Establishment Labs Holdings Ord (ESTA)
Spdr Ser Tr S&p Biotech (XBI)
Spdr Ser Tr S&p Biotech (XBI)
Peloton Interactive Cl A Com (PTON)
Peloton Interactive Cl A Com (PTON)
Grand Canyon Education Put Option (LOPE)
Grand Canyon Education Put Option (LOPE)
Imax Corp Cad (IMAX)

View all positions for Nantahala Capital Management

Top funds holding Astria Therapeutics

Perceptive Advisors
RA Capital Management
VR Adviser
Fairmount Funds Management
BlackRock
Vestal Point Capital
TCG Crossover Management
Vanguard Group
State Street Corporation
Millennium Management
Driehaus Capital Management
Citadel Advisors
Geode Capital Management
Affinity Asset Advisors
Nantahala Capital Management

View all funds holding Astria Therapeutics